Selected research
Industry Research
Donepezil for Alzheimer Industry Research Report 2026
Market perspective
The global Donepezil for Alzheimer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Donepezil for Alzheimer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Donepezil for Alzheimer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Donepezil for Alzheimer include Eisai, Teva, Sun Pharmaceutical, Novartis, Luoxin, Jishengtang Pharma, Pfizer, Hansoh Pharma and Dr Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Donepezil for Alzheimer market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Donepezil for Alzheimer Market by Company
Eisai
Teva
Sun Pharmaceutical
Novartis
Luoxin
Jishengtang Pharma
Pfizer
Hansoh Pharma
Dr Reddy's Laboratories
Cipla
ARK PHA.LTD
Apotex
Donepezil for Alzheimer Segment by Type
5mg
23mg
10mg
Donepezil for Alzheimer Segment by Application
Clinics
Hospitals
Drugstore
Donepezil for Alzheimer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil for Alzheimer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil for Alzheimer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil for Alzheimer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Donepezil for Alzheimer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Donepezil for Alzheimer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Donepezil for Alzheimer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 23mg
- 10mg
Applications
- Clinics
- Hospitals
- Drugstore
Companies covered
- Eisai
- Teva
- Sun Pharmaceutical
- Novartis
- Luoxin
- Jishengtang Pharma
- Pfizer
- Hansoh Pharma
- Dr Reddy's Laboratories
- Cipla
- ARK PHA.LTD
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Donepezil for Alzheimer Market Size (2021-2032)
- 2.2.2 Global Donepezil for Alzheimer Sales (2021-2032)
- 2.2.3 Global Donepezil for Alzheimer Market Average Price (2021-2032)
- 2.3 Donepezil for Alzheimer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5mg
- 2.3.3 23mg
- 2.3.4 10mg
- 2.4 Donepezil for Alzheimer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Drugstore
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Donepezil for Alzheimer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Donepezil for Alzheimer Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Donepezil for Alzheimer Revenue of Manufacturers (2021-2026)
- 3.4 Global Donepezil for Alzheimer Average Price by Manufacturers (2021-2026)
- 3.5 Global Donepezil for Alzheimer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Donepezil for Alzheimer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Donepezil for Alzheimer, Product Type & Application
- 3.8 Global Manufacturers of Donepezil for Alzheimer, Established Date
- 3.9 Global Donepezil for Alzheimer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai
- 4.1.1 Eisai Company Information
- 4.1.2 Eisai Business Overview
- 4.1.3 Eisai Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Donepezil for Alzheimer Product Portfolio
- 4.1.5 Eisai Recent Developments
- 4.2 Teva
- 4.2.1 Teva Company Information
- 4.2.2 Teva Business Overview
- 4.2.3 Teva Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Donepezil for Alzheimer Product Portfolio
- 4.2.5 Teva Recent Developments
- 4.3 Sun Pharmaceutical
- 4.3.1 Sun Pharmaceutical Company Information
- 4.3.2 Sun Pharmaceutical Business Overview
- 4.3.3 Sun Pharmaceutical Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sun Pharmaceutical Donepezil for Alzheimer Product Portfolio
- 4.3.5 Sun Pharmaceutical Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Donepezil for Alzheimer Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Luoxin
- 4.5.1 Luoxin Company Information
- 4.5.2 Luoxin Business Overview
- 4.5.3 Luoxin Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Luoxin Donepezil for Alzheimer Product Portfolio
- 4.5.5 Luoxin Recent Developments
- 4.6 Jishengtang Pharma
- 4.6.1 Jishengtang Pharma Company Information
- 4.6.2 Jishengtang Pharma Business Overview
- 4.6.3 Jishengtang Pharma Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jishengtang Pharma Donepezil for Alzheimer Product Portfolio
- 4.6.5 Jishengtang Pharma Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Donepezil for Alzheimer Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Hansoh Pharma
- 4.8.1 Hansoh Pharma Company Information
- 4.8.2 Hansoh Pharma Business Overview
- 4.8.3 Hansoh Pharma Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hansoh Pharma Donepezil for Alzheimer Product Portfolio
- 4.8.5 Hansoh Pharma Recent Developments
- 4.9 Dr Reddy's Laboratories
- 4.9.1 Dr Reddy's Laboratories Company Information
- 4.9.2 Dr Reddy's Laboratories Business Overview
- 4.9.3 Dr Reddy's Laboratories Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr Reddy's Laboratories Donepezil for Alzheimer Product Portfolio
- 4.9.5 Dr Reddy's Laboratories Recent Developments
- 4.10 Cipla
- 4.10.1 Cipla Company Information
- 4.10.2 Cipla Business Overview
- 4.10.3 Cipla Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cipla Donepezil for Alzheimer Product Portfolio
- 4.10.5 Cipla Recent Developments
- 4.11 ARK PHA.LTD
- 4.11.1 ARK PHA.LTD Company Information
- 4.11.2 ARK PHA.LTD Business Overview
- 4.11.3 ARK PHA.LTD Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ARK PHA.LTD Donepezil for Alzheimer Product Portfolio
- 4.11.5 ARK PHA.LTD Recent Developments
- 4.12 Apotex
- 4.12.1 Apotex Company Information
- 4.12.2 Apotex Business Overview
- 4.12.3 Apotex Donepezil for Alzheimer Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Apotex Donepezil for Alzheimer Product Portfolio
- 4.12.5 Apotex Recent Developments
5 Global Donepezil for Alzheimer Market Scenario by Region
- 5.1 Global Donepezil for Alzheimer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Donepezil for Alzheimer Sales by Region: 2021-2032
- 5.2.1 Global Donepezil for Alzheimer Sales by Region: 2021-2026
- 5.2.2 Global Donepezil for Alzheimer Sales by Region: 2027-2032
- 5.3 Global Donepezil for Alzheimer Revenue by Region: 2021-2032
- 5.3.1 Global Donepezil for Alzheimer Revenue by Region: 2021-2026
- 5.3.2 Global Donepezil for Alzheimer Revenue by Region: 2027-2032
- 5.4 North America Donepezil for Alzheimer Market Facts & Figures by Country
- 5.4.1 North America Donepezil for Alzheimer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Donepezil for Alzheimer Sales by Country (2021-2032)
- 5.4.3 North America Donepezil for Alzheimer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Donepezil for Alzheimer Market Facts & Figures by Country
- 5.5.1 Europe Donepezil for Alzheimer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Donepezil for Alzheimer Sales by Country (2021-2032)
- 5.5.3 Europe Donepezil for Alzheimer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Donepezil for Alzheimer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Donepezil for Alzheimer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Donepezil for Alzheimer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Donepezil for Alzheimer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Donepezil for Alzheimer Market Facts & Figures by Country
- 5.7.1 South America Donepezil for Alzheimer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Donepezil for Alzheimer Sales by Country (2021-2032)
- 5.7.3 South America Donepezil for Alzheimer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Donepezil for Alzheimer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Donepezil for Alzheimer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Donepezil for Alzheimer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Donepezil for Alzheimer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Donepezil for Alzheimer Sales by Type (2021-2032)
- 6.1.1 Global Donepezil for Alzheimer Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Donepezil for Alzheimer Sales Market Share by Type (2021-2032)
- 6.2 Global Donepezil for Alzheimer Revenue by Type (2021-2032)
- 6.2.1 Global Donepezil for Alzheimer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Donepezil for Alzheimer Revenue Market Share by Type (2021-2032)
- 6.3 Global Donepezil for Alzheimer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Donepezil for Alzheimer Sales by Application (2021-2032)
- 7.1.1 Global Donepezil for Alzheimer Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Donepezil for Alzheimer Sales Market Share by Application (2021-2032)
- 7.2 Global Donepezil for Alzheimer Revenue by Application (2021-2032)
- 7.2.1 Global Donepezil for Alzheimer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Donepezil for Alzheimer Revenue Market Share by Application (2021-2032)
- 7.3 Global Donepezil for Alzheimer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Donepezil for Alzheimer Value Chain Analysis
- 8.1.1 Donepezil for Alzheimer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Donepezil for Alzheimer Production Mode & Process
- 8.2 Donepezil for Alzheimer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Donepezil for Alzheimer Distributors
- 8.2.3 Donepezil for Alzheimer Customers
9 Global Donepezil for Alzheimer Analyzing Market Dynamics
- 9.1 Donepezil for Alzheimer Industry Trends
- 9.2 Donepezil for Alzheimer Industry Drivers
- 9.3 Donepezil for Alzheimer Industry Opportunities and Challenges
- 9.4 Donepezil for Alzheimer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst